In vitroand clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti‐aging and antioxidant activities
Open Access
- 11 January 2016
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 15 (2) , 150-157
Abstract
Isoprenylcysteine (IPC) small molecules were identified as a new class of anti-inflammatory compounds over 20 years ago. Since then, they have been developed as novel cosmetic functional ingredients (CFI) and topical drug candidates. SIG1273 is a second generation CFI that has previously been shown to provide a broad spectrum of benefits for the skin through its anti-inflammatory and antimicrobial properties. To determine whether SIG1273 possesses anti-aging properties in vitro and evaluate the tolerability and activity of SIG1273 when applied topically to human subjects. To model photoaging in vitro, human dermal fibroblasts (HDFs) were exposed in culture to UVA to induce collagenase (MMP-1) production. An in vitro wound-healing model was based on the activation of HDF migration into cell-free tissue culture surface. Hydrogen peroxide-induced oxidative stress was performed using HDFs to measure intracellular ROS activity. Radical scavenging capacity was determined using a colorimetric antioxidant assay kit (ABTS method). Lastly, a 4-week, 29-subject study was performed in which SIG1273 was applied topically as a cream to assess its tolerance and activity in reducing the appearance of aging. In vitro studies demonstrate SIG1273 inhibits UVA-induced MMP-1 production, hydrogen peroxide-induced oxidative stress and promotes wound healing. Moreover, SIG1273 was shown to be a radical scavenging antioxidant. Clinical assessment of SIG1273 cream (0.25%) showed it was well tolerated with significant improvement in the appearance of fine lines, coarse wrinkles, radiance/luminosity, pore size, texture/smoothness, hydration and increased firmness. SIG1273 represents a novel CFI with antioxidant, anti-aging, and anti-inflammatory properties that when applied topically is well tolerated and provides benefits to individuals with aging skin.Keywords
This publication has 31 references indexed in Scilit:
- Epigallocatechin-3-gallate prevents heat shock-induced MMP-1 expression by inhibiting AP-1 activity in human dermal fibroblastsArchives of Dermatological Research, 2013
- Cutaneous responses to environmental stressorsAnnals of the New York Academy of Sciences, 2012
- N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor γ Ligand with Partial and Full Agonist Activity in Vitro and in VivoJournal of Biological Chemistry, 2011
- Matrix-Degrading Metalloproteinases in PhotoagingJournal of Investigative Dermatology Symposium Proceedings, 2009
- Platelet lysate promotes in vitro wound scratch closure of human dermal fibroblasts: different roles of cell calcium, P38, ERK and PI3K/AKTJournal of Cellular and Molecular Medicine, 2008
- Decreased Collagen Production in Chronologically Aged SkinThe American Journal of Pathology, 2006
- Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugsSeminars in Cancer Biology, 2004
- Collagen Degradation in Aged/Photodamaged Skin In Vivo and After Exposure to Matrix Metalloproteinase-1 In VitroJournal of Investigative Dermatology, 2003
- Role of Isoprenylcysteine Carboxyl Methyltransferase in Tumor Necrosis Factor-α Stimulation of Expression of Vascular Cell Adhesion Molecule-1 in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Farnesylcysteine analogues inhibit chemotactic peptide receptor‐mediated G‐protein activation in human HL‐60 granulocyte membranesFEBS Letters, 1993